Innovation & Excellence

Leading Innovation in Precision Genomics

At Rophevac, our Research & Development is at the heart of everything we do. We are committed to pioneering innovative genomic solutions that transform healthcare and improve patient outcomes across India and globally.

Technologies

Advanced platforms and tools driving discovery

Sequencing Technologies

Advanced sequencing platforms including Illumina NovaSeq, NextSeq, Oxford Nanopore, and PacBio.

Learn More

Molecular Profiling Technologies

Digital PCR, qPCR, microarray platforms, and mass spectrometry for comprehensive molecular analysis.

Learn More

Imaging & Analysis Technologies

Flow cytometry, digital pathology, and FISH for immunophenotyping and chromosomal analysis.

Learn More

Bioinformatics Infrastructure

High-performance computing, cloud computing, and petabyte-scale data storage for genomic analysis.

Learn More

Proprietary Platforms

VarMiner, OncoMiner, and BioBank Repository for variant interpretation and sample management.

Learn More

About Rophevac R&D

Rophevac's R&D operations are focused on advancing genetic testing technologies, developing precision medicine solutions, and creating next-generation diagnostic tools that enable early disease detection, accurate diagnosis, and personalized treatment strategies.

200+

Scientific Publications

50+

Patents Filed

500K+

Tests Performed Annually

20-25%

Revenue in R&D